Intracranial dural arteriovenous fi stulae (DAVF) are uncommon vascular lesions usually diagnosed in the fi fth and sixth decades of life. Although DAVF historically were considered congenital, benign lesions, it is now understood that most represent acquired lesions. Their clinical manifestations and natural history may range from benign to aggressive, primarily depending on their angioarchitectural features. In part II of this 3-part series, we review the clinical presentation, natural history, and diagnosis of intracranial DAVF.
Clinical Presentation
Clinical manifestations of DAVF are a direct result of their anatomic location and presence of retrograde leptomeningeal venous drainage (RLVD). RLVD leads to the development of venous hypertension, which in turn may be responsible for the presence of seizures, ocular dysfunction, loss of function because of ischemia/congestion, and subdural, subarachnoid, or intracerebral hemorrhage. Among patients with high-grade lesions (Borden types II and III), those who are symptomatic are at the greatest risk of hemorrhage.
It cannot be overemphasized that no location is immune from harboring lesions capable of an aggressive presentation. DAVF location itself only raises the suspicion of dangerous venous anatomy in certain intracranial DAVF, such as in tentorial and anterior cranial fossa DAVF. Transverse-sigmoid junction DAVF may be asymptomatic or cause pulsatile tinnitus because of the presence of high fl ow and turbulence. However, when RLVD is present, DAVF can cause signs and symptoms of temporal lobe dysfunction or hemorrhage. Ocular hypertension is the hallmark of cavernous DAVF and is caused by retrograde drainage in the ophthalmic veins. Symptoms and signs may include exophthalmos, chemosis, conjunctival injection, and most importantly visual loss (Figure 1 ).
Tentorial and anterior cranial fossa DAVF are associated with a high rate of intracerebral hemorrhage as their fi rst presentation. This is not unexpected, given the presence of RLVD in virtually all cases. Less commonly, tentorial DAVF can cause cranial nerve palsies (compression from dilated veins), decreased level of consciousness and dementia (venous congestion of the diencephalon), or even cervical myelopathy (venous congestion of the brainstem and cervical cord). Finally, patients with DAVF of the superior sagittal sinus may present with seizures, dementia, and symptoms of intracranial hypertension.
Diagnosis
The diagnosis of intracranial DAVF is based on clinical suspicion and imaging studies. Lesions presenting with symptoms of increased blood fl ow are often associated with an audible bruit heard with a stethoscope over the area of interest. It has been our experience that in patients who present with subjective pulsatile tinnitus but have no audible bruit over the mastoid area, the presence of an underlying transverse-sigmoid sinus fi stula can be virtually excluded.
MRI often provides indirect clues for the presence of DAVF, such as the presence of prominent cortical veins (high fl ow on T2-weighted sequences) or increased area of vascularity in the region of a major dural sinus (on contrast-enhanced images). Venous hypertension will usually produce abnormal signal on fluid attenuated inversion recovery and T2-weighted sequences, whereas venous infarction is characterized by increased signal on diffusion-weighted images.
Long-standing venous hypertension may be associated with calcifi cations of multiple dilated perimedullary venules, which may be evident on unenhanced CT scans (Figure 2 ). More recent techniques such as time-resolved magnetic resonance angiography are promising and have been used for diagnosis and follow-up. However, catheter angiography remains the gold standard for the detection and classifi cation of DAVF (Figure 3 ). Cerebral angiography is of paramount importance in defi ning the pattern of leptomeningeal venous drainage and other angioarchitectural features, such as the presence of varices along draining veins or evidence of outfl ow obstruction, which will be important in treatment decision making.
Natural History
Available data on the natural history of intracranial DAVF have been derived mainly from small single-center retrospective series. The venous drainage pattern of the fi stula is considered a crucial determining factor of the natural history of these lesions. As such, the presence of RLVD predicts an aggressive behavior in terms of intracranial hemorrhage and nonhemorrhagic neurologic defi cits (NHND). The location of the fi stula may also predispose to a more aggressive behavior. For instance, tentorial, superior petrosal sinus, and anterior cranial fossa DAVF are more prone to present with hemorrhage. However, this is thought to be related to a higher frequency of RLVD rather than the anatomic location.
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In contrast, intracranial DAVF with RLVD are associated with signifi cant morbidity, and patients commonly present with hemorrhage or neurologic deficits with progressive symptoms. Once the lesion becomes symptomatic, there is a high risk of further neurologic events. For instance, rebleeding within the fi rst 2 weeks after initial hemorrhage can occur in up to 35% of patients. In addition, long-term follow-up of symptomatic patients refusing treatment or with partially treated lesions revealed an annual event rate of 15% (8.1% and 6.9% annual risk of hemorrhage and NHND, respectively) and an annual mortality rate of 10.4%. The annual hemorrhage rate is even higher in lesions with venous outfl ow ectasia.
The wide availability of high-resolution imaging studies has increased the number of incidentally discovered intracranial DAVF. Recent evidence suggests that the risk of hemorrhage or neurologic defi cit in patients with asymptomatic DAVF with RLVD might be lower than that of patients with symptoms or a hemorrhagic presentation. However, these data should be 
